Pertuzumab Plus Trastuzumab With or Without Chemotherapy Followed by Emtansine in ERBB2-Positive Metastatic Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Nom du journal : JAMA Oncol
Année : 2023
Volume : 9
Page de départ : 1381-1389
